CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent
Bon San Koo, Seokchan Hong, You Jae Kim, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo
Korean J Intern Med. 2015;30(1):104-109.   Published online 2014 December 30    DOI: https://doi.org/10.3904/kjim.2015.30.1.104

Excel Download

Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent
The Korean Journal of Internal Medicine. 2015;30(1):104   Crossref logo
Link1 Link2 Link3

Pathology of Interstitial Lung Disease in Patients with Rheumatoid Arthritis
Lung Disease Associated with Rheumatoid Arthritis. 2018;91-116   Crossref logo
Link1

Mortality Rates Among Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: Comment on the Article by Simard et al
Arthritis & Rheumatism. 2013;65(6):1670-1671   Crossref logo
Link1

Comprehensive Understanding of Interstitial Lung Disease in Rheumatoid Arthritis
Lung Disease Associated with Rheumatoid Arthritis. 2018;81-90   Crossref logo
Link1

Rheumatoid Arthritis-Associated Interstitial Lung Disease
Respiratory Medicine. 2017;109-119   Crossref logo
Link1

Outcomes After Switching From One Anti–Tumor Necrosis Factor α Agent to a Second Anti–Tumor Necrosis Factor α Agent in Patients With Rheumatoid Arthritis: Results From a Large UK National Cohort Study
Yearbook of Medicine. 2008;2008:6-7   Crossref logo
Link1 Link2

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents
Arthritis & Rheumatism. 2007;56(5):1417-1423   Crossref logo
Link1 Link2

Radiological Characteristics of Interstitial Lung Diseases in Patients with Connective Tissue Disease: Focus on Rheumatoid Arthritis
Lung Disease Associated with Rheumatoid Arthritis. 2018;117-140   Crossref logo
Link1

Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor
Arthritis & Rheumatism. 2008;58(5):1258-1263   Crossref logo
Link1 Link2

Therapeutic Strategies for Interstitial Lung Diseases in Rheumatoid Arthritis
Lung Disease Associated with Rheumatoid Arthritis. 2018;141-148   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.